Speakers

Roger Adami, PhD

Senior Director, Pharm. Sci

Nitto BioPharma, Inc.

Firoz Antia, PhD

Head of Oligonucleotide Development

Biogen

Lilit Avagyan

Team Leader Customized Solutions

Knauer

Kerry Benenato

Chief Platform Officer

Sail Biomedicines

Kerry Benenato, PhD

Vice President, Platform Chemistry and Formulation Discovery

Moderna Therapeutics

Dana Chreng

Director, Manufacturing & Operations

Ionis

Michelle Colgrave, PhD

Professor of Food & Agricultural Proteomics

Edith Cowan University

David Corey, PhD

Professor of Pharmacology and Biochemistry

UT Southwestern

Cecilia Cotta-Ramusino, PhD

Senior Vice President – Head of Platform

Tessera Therapeutics

David Craik, PhD

Professor of Biomolecular Structure

University of Queensland

Steven Dowdy

Professor

UCSD School of Medicine, USA

Wayne Doyle

Head of Platform

Eclipse Bioinnovations

Jeremy Duffield, MD, PhD, FRCP

Chief Scientific Officer

Prime Medicine

Ralf Eisenhuth

Process Manager Chromatography and Technology Transfer

Bachem

Kris Elverum

President and CEO

Turnstone Biologics

Cecilia Fernández, Ph.D.

VP of Strategic Planning and Operations

Chroma Medicine

Fred Fleitz

Group Vice President, CMC

Arrowhead Pharmaceuticals

Andrew Geall, PhD

Co-founder and Chief Development Officer

Replicate Bioscience

Robert Gronke, PhD

Senior Principal Scientist

Biogen, Inc

Sonia Henriques

Associate Professor in Biochemistry

The University of Queensland

Roman Hillebrand, Ph.D.

Associate Director of Manufacturing Innovation

Arrowhead Pharmaceuticals

Aimee Jackson, PhD

Chief Scientific Officer

Atalanta Therapeutics

Martin Johnson

Scientist

Eli Lilly

Priya Karmali, PhD

Chief Technology Officer

Capstan Therapeutics

Miriam Kidron

Chief Scientific Officer and Director

Oramed Pharmaceuticals Inc.

Troels Koch, PhD

Chief Technology Officer

MiNa Therapeutics

Michael Kopach, PhD

Associate Vice President, Synthetic Molecule Design and Development

Eli Lilly and Company

Andreas Kuhn, PhD

Senior Vice President RNA Biochemistry & CMC Development

BioNTech SE

Jayesh Kulkarni

Co-Founder & Chief Scientific Officer

NanoVation Therapeutics

Frederic Lamaty, Ph.D.

Director of Research, Head of Green Chemistry Team

University of Montpellier

Nicole Lawrence, PhD

Senior Research Fellow

Institute for Molecular Bioscience and Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland

Susan Li, PhD

Peptide Chief Scientist

Asymchem

Jory Lietard

Associate Professor

University of Vienna

Karsten Lindhardt, MSc, PhD, DBE

CEO

Biograil

Ewa Lis, PhD

Founder and CEO

Koliber Biosciences

Troy Lister

Chief Scientific Officer

Verve Therapeutics

Fa Liu, PhD

Chief Scientific Officer

Full-Life Technologies

Olivier Ludemann-Hombourger, PhD

Director, Global Innovation and Technology

PolyPeptide Group

Harris Makatsoris

Academics Professor of Sustainable Manufacturing Systems

King's College London

Muthiah (Mano) Manoharan, PhD

Senior Vice President of Drug Discovery

Alnylam Pharmaceuticals

Takuya Miyagawa

Research Associate

Sumitomo Chemical Co., Ltd.

Alison Moore

Chief Technical Officer

Codexis

Swagatam Mukhopadhyay, PhD

Co-founder & Chief Scientific Officer

Creyon Bio

Lubomir Nechev, PhD

Senior Vice President CMC Development

Alnylam Pharmaceuticals

Yoshitaka Nemoto

Vice President R&D

PeptiStar

Rubina Parmar, PhD

Vice President, Chemistry and Delivery Sciences

Intellia Therapeutics

Tao Pei, PhD

Senior Vice President, Chemistry

Arrowhead Pharmaceuticals

El Djouhar Rekaï, PhD

Head of Peptide Process Development & Manufacturing

PolyPeptide Group

Claus Rentel, PhD

Vice President, Analytical Development/QC

Ionis Pharmaceuticals, Inc.

Syed Reza, MD, PhD

Scientific and Sales Consultant

NOF Corporation

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Dr Cole Seifert, PhD

Research & Technology Specialist

Croda Inc.

Laura Sepp-Lorenzino, PhD

EVP, Chief Scientific Officer

Intellia Therapeutics

Trishul Shah, M.S.

Global Sales and Marketing (interim), Head of Sales, Americas

PolyPeptide Laboratories Inc.

Chikdu Shivalila, PhD

Senior Director of Platform Biology

Wave Life Sciences

Sirat Sikka

Senior Scientist, Applications and Innovation

Thermo Fisher Scientific

Stephen Spagnol, PhD

Director, Enabling Technologies

Merck

G. Susan Srivatsa, PhD

President

ElixinPharma

Hiroaki Suga, PhD

Professor of Chemistry, School of Science

University of Tokyo, Japan

Ali Tavassoli, Ph.D.

CSO, Curve Therapeutics

University of Southampton

Barry Ticho

Chief Medical Officer

Stoke Therapeutics

Sho Toyonaga

Director, Drug Delivery Research

FUJIFILM Pharmaceuticals U.S.A., Inc

Sonia Vallabh, PhD

Senior Group Leader

Broad Institute of MIT & Harvard

Chandra Vargeese, PhD

Chief Technology Officer

Wave Life Science

Thomas Vrucina

Deputy Head Liposome Technology

Polymun Scientific

Liron Walsh, M.D.

Vice President, Head of Development

Intellia Therapeutics

Mike Webb, Ph.D.

Founder and CEO

Mike Webb Pharma

Fran Wincott, PhD

President

Wincott & Associates, LLC

Ed Yaworski

Chief Technology Officer

Genevant Sciences Corp

Xuan Zhou

Senior Scientist, Oligonucleotide Development

Biogen

Helge Zieler, PhD

CEO

Primrose Bio

John Zuris

Director, Editing Technologies

Editas Medicine